Pain & Neuropathy Clinic - Premium Medical Services

$1.2M

Revenue

$690K

SDE

2.8x

Multiple

Subscribe Free

Read the full deal writeup

Get Free Access

Already a member? Sign in

Full Editorial Writeup

This is a high-end, non-invasive medical clinic specializing in chronic pain, neuropathy treatment, and body contouring services in a major Colorado metro market. Launched in 2024, the business operates on a package-based treatment model rather than traditional fee-for-service, creating predictable revenue streams through 8-12 week programs ranging from $3,000 to $12,000 per patient. The clinic serves approximately 150 active patients monthly, predominantly aged 50+ with an even gender split, and maintains a 25% retention rate for post-treatment maintenance programs.

The business has achieved national recognition as a top 5 clinic for Dahlia Red Light utilization and demonstrates strong operational momentum with 20%+ monthly growth through early 2026. Their service delivery relies on repeatable clinical protocols executed by trained staff, including advanced regenerative therapies and premium body contouring treatments. The clinic operates Monday through Friday (half-day Friday) with structured appointment scheduling that maintains 1-2 week advance bookings, supported by strategic vendor partnerships and an 80% sales conversion rate on qualified leads.

Why we like it

Predictable cash model with high-ticket packages generating $180k monthly revenue from just 150 patients. The 8-12 week treatment programs create visibility into future cash flows, while the $3k-$12k average program values deliver strong unit economics that aren't dependent on insurance reimbursements.
Defensible market position in growing demographic tailwinds with aging population driving chronic pain and neuropathy demand. National recognition as top 5 Dahlia Red Light clinic creates competitive moat, while the premium positioning and specialized protocols make this harder to replicate than generic healthcare services.
Operationally scalable model with systems-dependent delivery rather than owner-dependent expertise. The repeatable clinical protocols enable staff execution of most treatments, and the current 80% close rate with structured vendor partnerships demonstrates predictable lead generation and conversion.
Clear capacity expansion opportunities without major capital requirements. Current Monday-Thursday schedule with half-day Friday leaves obvious room for extended hours, weekend slots, or additional treatment rooms in nearby space to drive immediate revenue growth.

How to improve it

Extend operating hours immediately to capture unmet demand, starting with full Friday operations and select evening appointments. The current schedule leaves 20-30% capacity unused, representing $200k+ annual revenue opportunity with minimal incremental costs.
Hire licensed medical provider to add injection and hormone therapy services within first 90 days. These high-margin services align perfectly with existing 50+ patient base and could add $150k+ annual revenue per the clinic's growth projections.
Implement systematic upselling program to increase the 25% post-treatment retention rate to 40%+ through structured maintenance packages. With 150 monthly patients, a 15% retention improvement represents $270k additional annual recurring revenue.
Optimize vendor partnership agreements to push the 80% close rate to the projected 90% through better lead qualification and deposit requirements. This single improvement could add $120k annually in converted revenue from existing lead flow.
Add second treatment room in nearby space to accommodate higher patient volume without operational bottlenecks. The infrastructure investment would support 200+ monthly active patients, representing $360k additional annual capacity.
Develop systematic referral program leveraging the strong word-of-mouth reputation to reduce customer acquisition costs. Structured incentives for existing patients could reduce marketing spend while maintaining growth trajectory.
Implement advanced scheduling and patient management software to reduce administrative overhead and improve treatment completion rates. Better systems could increase staff efficiency and patient satisfaction while reducing owner involvement.
Explore franchise or licensing opportunities for proven treatment protocols once optimization is complete. The repeatable systems and national recognition create potential for multi-location expansion or licensing revenue streams.

Diligence notes

Verify the claimed 20%+ monthly growth rate and validate whether January-February $90k monthly revenue represents sustainable run rate or seasonal peak. Request month-by-month revenue data for 2025-2026 to understand true growth trajectory and seasonality patterns.
Deep dive into the vendor partnership agreements that generate leads and examine concentration risk in patient acquisition. Understand terms, exclusivity arrangements, and what happens if key vendor relationships terminate or pricing changes significantly.
Analyze patient retention and lifetime value metrics beyond the stated 25% post-treatment retention rate. Review actual patient cohort data, average treatment completion rates, and revenue per patient over time to validate unit economics and churn assumptions.
Examine regulatory compliance and licensing requirements for the specialized treatment protocols, particularly around the Dahlia Red Light therapy and regenerative treatments. Ensure all equipment certifications, staff licensing, and treatment protocols meet current regulatory standards and assess ongoing compliance costs.

Source

Originally listed on BusinessBroker.net. View original listing →